Blood-Based Biomarkers and Cognitive-Behavioral Assessment in Mild Traumatic Brain Injury: Current Evidence and...

Area of Science:

• Neuroscience
• Clinical Medicine
• Biomarkers

Background:

• Mild traumatic brain injury (mTBI) is common but difficult to evaluate using conventional methods.
• Neuroimaging often fails to detect subtle abnormalities or explain functional deficits.
• Blood-based biomarkers and cognitive assessments are crucial for understanding mTBI consequences.

Purpose of the Study:

• To review blood-based biomarkers and cognitive/behavioral assessment tools for mTBI.
• To discuss the limitations of current evaluation methods.
• To propose an integrated approach for comprehensive mTBI patient management.

Main Methods:

• Literature review of blood-based biomarkers in mTBI.
• Analysis of cognitive and behavioral assessment tools for mTBI.
• Discussion of the combined interpretation of biomarkers and functional assessments.

Main Results:

• Blood biomarkers can indicate tissue injury and aid in reducing CT scans.
• Cognitive assessments reveal functional impairments like attention and memory deficits.
• Both methods have limitations influenced by timing, comorbidities, and patient effort.

Conclusions:

• Neither blood biomarkers nor cognitive tests alone are sufficient for mTBI evaluation.
• An integrated approach combining both is necessary for precise and individualized patient management.
• This integrated strategy can improve the comprehensive assessment of mTBI patients.